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Cyanobacteria produce a wide range of lipopeptides that exhibit potent membrane-
disrupting activities. Laxaphycins consist of two families of structurally distinct
macrocyclic lipopeptides that act in a synergistic manner to produce antifungal and
antiproliferative activities. Laxaphycins are produced by range of cyanobacteria but
their biosynthetic origins remain unclear. Here, we identified the biosynthetic pathways
responsible for the biosynthesis of the laxaphycins produced by Scytonema hofmannii
PCC 7110. We show that these laxaphycins, called scytocyclamides, are produced by
this cyanobacterium and are encoded in a single biosynthetic gene cluster with shared
polyketide synthase enzymes initiating two distinct non-ribosomal peptide synthetase
pathways. The unusual mechanism of shared enzymes synthesizing two distinct types
of products may aid future research in identifying and expressing natural product
biosynthetic pathways and in expanding the known biosynthetic logic of this important
family of natural products.
Keywords: synergy, biosynthesis, natural product, laxaphycin, scytocyclamide, antifungal, cupin,
dehydrobutyrine
INTRODUCTION
Natural products are small molecules produced by living organisms (Newman and Cragg,
2016). Research interest in natural products is focused on the discovery of new molecules with
pharmaceutical applications (Spainhour, 2005; Newman and Cragg, 2016). Natural products often
have complex chemical structures with rare chemical moieties that allow them to react with
specific molecular targets and to kill or inhibit the growth of other organisms (Rodrigues et al.,
2016). Cyanobacteria produce a wide variety of natural products with potent bioactivities (Demay
et al., 2019; Huang and Zimba, 2019). Characterization of new natural products offers starting
material for drug design as new active structures (Rodrigues et al., 2016). Characterization of
the biosynthesis of these products advance methods in production of the structures through
combinatorial biosynthesis (Kim et al., 2015). Many microbial and cyanobacterial natural products
are synthesized by polyketide synthases (PKS) and non-ribosomal peptide synthetases (NRPS)
(Kehr et al., 2011; Dittmann et al., 2015). PKS and NRPS enzymes often act together and are
encoded in joint biosynthetic gene clusters producing hybrid PKS/NRPS products (Miyanaga et al.,
2018). PKS and NRPS enzymes allow the production of complex structures with characteristic
non-proteinogenic amino acids and the combination of non-ribosomal peptides (NRP) with
polyketide chains and decorations (Evans et al., 2011). NRPS and PKS biosynthesis typically follows
a colinearity rule, where the number and order of the catalytic domains correspond to the amino
acid number, order and structure in the product (Guenzi et al., 1998; Callahan et al., 2009).
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Laxaphycins are cyanobacterial cyclic lipopeptides that fall
in two distinct structural macrocycles consisting of either 11
amino acids (known as A-type laxaphycins) or 12 amino acids
(known as B-type laxaphycins) (Frankmölle et al., 1992a; Luo
et al., 2015). Both types include β-aminooctanoic acid (Aoa) or
β-aminodecanoic acid (Ada) (Table 1). Eleven- and 12-residue
laxaphycins have strong synergistic activity in antifungal and
antiproliferative bioactivity assays (Frankmölle et al., 1992b;
MacMillan et al., 2002; Cai et al., 2018). Laxaphycins are
hypothesized to be produced by the PKS/NRPS hybrid pathway
(Bornancin et al., 2015, 2019). However, the biosynthetic origins
of members of the laxaphycin family remains unclear. Despite
sharing the same name, they are chemically distinct and are
anticipated to be produced by distinct pathways (Bornancin et al.,
2015, 2019). The nomenclature of laxaphycins is complicated
due to the two distinct core types addressed as a single family
combined with naming new members after the producing
organisms and distinguishing variants with lettering complicates
(Table 1). Therefore, we refer to the two types as 11- and 12-
residue laxaphycins. There are 30 diverse members assigned
to the laxaphycin family reported to date (Table 1). The first
laxaphycins to exhibit synergistic effects were described from
Anabaena laxa (Frankmölle et al., 1992a,b). Here, we focused
on laxaphycin variants called scytocyclamides produced by
Scytonema hofmannii PCC 7110 (Grewe, 2005). S. hofmannii
PCC 7110 was previously studied by our group and a methanol
crude extract of the cells was antifungal but the active agent was
not identified (Shishido et al., 2015).
Here we describe the biosynthetic pathways responsible for
the biosynthesis of scytocyclamides from S. hofmannii PCC 7110.
We show that the two types of scytocyclamides are synthesized
by a branched NRPS/PKS biosynthetic pathway. These pathways
encode shared loading PKS enzymes that initiate two distinct
NRPS pathways exceptionally to the colinearity rule. We also
report the synergistic antifungal activity of scytocyclamides and
three new laxaphycin variants (scytocyclamides A2, B2, and B3).
MATERIALS AND METHODS
Scytocyclamide Purification
Scytonema hofmannii PCC 7110 was grown in 5-L Erlenmeyer
flasks with 2.7 L modified Z8 medium without source of
combined nitrogen (Supplementary Table S1) at 20–21◦C with
photon irradiation of 3–7 µmol m−2 s−1 with constant sterilized
air bubbling for 3–5 weeks. Cells were collected by decanting
excess media and centrifugation at 8000 × g for 5 min. Cells
were frozen at −80◦C and freeze-dried with CHRIST BETA 2–
8 LSC plus freeze drier with a LYO CUBE 4–8 chamber. The total
amount of freeze-dried biomass was 4 g.
For each gram of dry cells, 30 ml of methanol was
used and the mixture was homogenized with Heidolph Silent
crusher M at 20 000 rpm for 30 s. The suspension was
centrifuged 10,000 × g for 5 min and supernatant was collected.
Extraction of the precipitate was repeated with 30 ml of
methanol. Chromatorex (Fuji-Davison Chemical Ltd., Aichi,
Japan) chromatography silica ODS powder (10 ml) was added
to the supernatant pool and the mixture was dried with
rotary evaporator Büchi Rotavapor R-200 at 30◦C. Solid phase
extraction (SPE) was performed with Phenomenex SPE strata
SI-1 silica 5 g/20 ml column, preconditioned with 20 ml
isopropanol and 20 ml of heptane. Silica ODS powder with
the dry extract was added to the column and extracted with
heptane, ethyl acetate, acetone, acetonitrile, and methanol with
each fraction collected individually. Fractions were dried with
nitrogen gas flow and re-dissolved in 1 ml of methanol for
bioactivity assays. The active methanol fraction was further
fractionated with liquid chromatography. Chromatography was
performed with an Agilent 1100 Series liquid chromatograph
with a Phenomenex Luna 5 µm C18(2) (150 × 10 mm, 100 Å)
column. The sample was injected in 100-µl batches and eluted
with acetonitrile/isopropanol 1:1 (solvent B) and 0.1% HCOOH
(solvent A) with a flow rate of 3 ml min−1 in the following
four stages: 1, isocratic stage of 43% solvent B in A for 15 min;
2, a linear gradient of solvent B from 43% to 60% in 10 min;
3, a linear gradient of solvent B from 60% to 81% in 5 min;
and 4, a linear gradient of solvent B from 81% to 100% in
6 min. Six scytocyclamide fractions were collected, dried with
nitrogen, and weighed.
3-Hydroxyleucine Feeding Experiment
Scytonema hofmannii PCC 7110 was grown in 100-mL
Erlenmeyer flasks with 41 mL modified Z8 medium without
a source of combined nitrogen with 40 µM of racemic 3-
OHLeu mixture of all four isomers (2-Amino-3-hydroxy-4-
methylpentanoic acid, ABCR) to determine if 3-OHLeu is utilized
as a substrate in scytocyclamide production. Control cultivations
were grown on the same medium without added 3-OHLeu. For
both media, three duplicates were cultivated at 20–21◦C with
photon irradiation of 3–7 µmol m−2 s−1 for 17 days. Cells
were collected by decanting excess media and centrifugation
8000 × g for 5 min. Cells were frozen at −80◦C and freeze-
dried with CHRIST BETA 2–8 LSC plus with a LYO CUBE 4–8
freeze drier. Freeze-dried biomass was weighed and extracted
with 0.5 ml methanol and glass beads (0.5-mm glass beads,
Scientific Industries Inc., United States) using a FastPrep cell
disrupter two times for 25 s at a speed of 6.5 m s−1. Samples were
centrifuged at room temperature for 5 min at 10 000 × g and
supernatant was collected.
Peptide Identification by LC-MS
Scytonema hofmannii PCC 7110 was grown in 500-mL
Erlenmeyer flasks of with 250 mL modified Z8 medium
without a source of combined nitrogen at 20–21◦C with
photon irradiation of 3–7 µmol m−2 s−1 with constant
sterilized air bubbling for 4 weeks. Cells were collected by
decanting excess media and centrifugation at 8000 × g for
5 min. Cells were frozen at −80◦C and freeze-dried with
CHRIST BETA 2–8 LSC plus with a LYO CUBE 4–8 freeze
drier. Freeze-dried cells (100 mg) were extracted with 1 ml
methanol and glass beads (0.5-mm glass beads, Scientific
Industries Inc., United States) using a FastPrep cell disrupter
two times for 25 s at a speed of 6.5 m s−1. Samples were
centrifuged at room temperature for 5 min at 10 000 × g.
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TABLE 1 | Amino acid sequence of laxaphycin variants.
Amino acid residue Ref.
11-residue laxaphycins 1 2 3 4 5 6 7 8 9 10 11
Laxaphycin A Aoa Hse Dhb OHPro HSe Phe Leu Ile Ile Leu Gly 1
Laxaphycin A2 Aoa Hse Dhb OHPro HSe Phe Leu Val Ile Leu Gly 10
Laxaphycin E Ada Hse Dhb OHPro HSe Phe Leu Ile Ile Leu Gly 1
Hormothamnin A Aoa Hse Dhb OHPro HSe Phe Leu Ile Ile Leu Gly 2
Lobocyclamide A Aoa Ser Dhb OHPro HSe Tyr Leu Ile Ile Leu Gly 3
Trichormamide A Ada Ser Ser Pro Ser Tyr Leu Ile Ile Pro Gly 7
Trichormamide D Ada Gln Dhb Pro Ser Tyr Leu Val Phe Leu Gly 8
Scytocyclamide A Aoa Gln Dhb OHPro HSe Phe Leu Ile Ile Leu Gly 4
[L-Val8]laxaphycin A Aoa Hse Dhb OHPro HSe Phe Leu Val Ile Leu Gly 11
[D-Val9]laxaphycin A Aoa Hse Dhb OHPro HSe Phe Leu Ile Val Leu Gly 11
Acyclolaxaphycin A H-Aoa Hse Dhb OHPro HSe Phe Leu Ile Ile Leu Gly-OH 11
[des-Gly11] acyclolaxaphycin A H-Aoa Hse Dhb OHPro HSe Phe Leu Ile Ile Leu-OH 11
[des-(Leu10-Gly11)] acyclolaxaphycin A H-Aoa Hse Dhb OHPro HSe Phe Leu Ile Ile-OH 11
12-residue laxaphycins 1 2 3 4 5 6 7 8 9 10 11 12 Ref.
Laxaphycin B Ada Val OHLeu Ala OHLeu Gln NMe-Ile OHAsn Thr Pro Leu Thr 1
Laxaphycin B2 Ada Val OHLeu Ala Leu Gln NMe-Ile OHAsn Thr Pro Leu Thr 5
Laxaphycin B3 Ada Val OHLeu Ala OHLeu Gln NMe-Ile OHAsn Thr OHPro Leu Thr 5
Laxaphycin B4 Ada Val OHLeu Hse OHLeu Gln NMe-Ile OHAsn Thr OHPro Leu Thr 10
Laxaphycin B5 Ada Ile OHLeu Val OHLeu Gln NMe-Ile Asn Thr Pro Tyr Thr 12
Laxaphycin B6 Ada Ile OHLeu Val Leu Gln NMe-Ile Asn Thr Pro Tyr Thr 12
Laxaphycin D Aoa Val OHLeu Ala OHLeu Gln NMe-Ile OHAsn Thr Pro Leu Thr 1
Lobocyclamide B Ada Val OHLeu Ala OHLeu Gln NMe-Ile OHThr Thr OHPro Leu Thr 3
Lobocyclamide C Aoa Val OHLeu Ala OHLeu Gln NMe-Ile OHThr Thr OHPro Leu Thr 3
Lyngbyacyclamide A Ada Val OHLeu Hse Leu Gln NMe-Ile OHAsn Thr Pro Phe Thr 6
Lyngbyacyclamide B Ada Val OHLeu Hse Leu Gln NMe-Ile OHAsn Thr OHPro Phe Thr 6
Trichormamide B Ada Ile OHLeu Hse OHLeu Gln NMe-Ile Ser Thr Pro Tyr Thr 7
Trichormamide C Ada Val OHLeu Ala OHLeu Gln NMe-Ile Asn Thr Pro Leu Thr 8
Acyclolaxaphycin B Ada Val OHLeu-OH H-Ala OHLeu Gln NMe-Ile OHAsn Thr Pro Leu Thr 9
Acyclolaxaphycin B3 Ada Val OHLeu-OH H-Ala OHLeu Gln NMe-Ile OHAsn Thr OHPro Leu Thr 9
Scytocyclamide B Aoa Val OHLeu Ala OHLeu Gln NMe-Ile OHAsn Thr Pro Leu Thr 4
Scytocyclamide C Aoa Val OHLeu Ala Leu Gln NMe-Ile OHAsn Thr Pro Leu Thr 4
1 Frankmölle et al. (1992b), 2 Gerwick et al. (1992), 3 MacMillan et al. (2002), 4 Grewe (2005), 5 Bonnard et al. (2007), 6 Maru et al. (2010), 7 Luo et al. (2014), 8 Luo
et al. (2015), 9 Bornancin et al. (2015), 10 Cai et al. (2018), 11 Bornancin et al. (2019), 12 Sullivan et al. (2020). Aoa – β-aminooctanoic acid, Ada - β-aminodecanoic
acid, Hse - Homoserine, Dhb - Dehydrobutyrine, NMe-Ile – N-Methyl Isoleucine, OHPro – 4-hydroxyproline, OHAsn – 3-hydroxyasparagine, OHLeu – 3-hydroxyleucine,
OHThr – 4-hydroxythreonine.
The supernatant was collected and extraction was repeated with
1 ml of methanol.
Extracts and purified scytocyclamide methanol solutions were
analyzed with UPLC-QTOF (Acquity I-Class UPLC-Synapt G2-
Si HR-MS, Waters Corp., Milford, MA, USA) equipped with
a Kinetex C8 column (2.1 × 50 or 100 mm, 1.7 µm, 100 Å,
Phenomenex, Torrance, CA, United States). The equipment
was injected with 0.5 or 1 µl samples, eluted at 40◦C with
0.1% HCOOH in water (solvent A) and acetonitrile/isopropanol
1:1, + 0.1% HCOOH (solvent B) with a flow rate of 0.3 ml
min−1. Two solvent gradients were used. 5% solvent B to
100% solvent B in 5 min, maintained for 2 min, back to
5% B in 0.50 min, and maintained for 2.50 min before next
run. Alternatively, 10% solvent B to 70% of solvent B in
5 min, then to 95% of solvent B in 0.01 min, maintained
for 1.99 min, then back to 10% of solvent B in 0.5 min,
and finally maintained for 2.5 min before the next run.
QTOF was calibrated using sodium formate and Ultramark
1621, which yielded a calibrated mass range from m/z 91
to 1921. Leucine Enkephalin was used at 10-s intervals as
a lock mass reference compound. Mass spectral data were
accumulated in positive electrospray ionization resolution mode.
The MSE Trap Collision Energy Ramp Started from 40.0 eV and
ended at 70.0 eV.
Bioactivity Assays
The same S. hofmannii PCC 7110 methanol extract used
for peptide identification LC-MS was used for antimicrobial
activity screening. The screening was performed with fungal
and bacterial strains (Table 2). The following samples were
pipetted directly on spots on agar: 50 µl cyanobacterial cellular
methanol extract, 50 µl negative control (methanol), and 10 µl
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TABLE 2 | Strains used in bioassays.
Organism Strain Medium Incubation
temperature
Fungi
Candida albicans FBCC 2462 PDA 28◦C
Candida guilliermondii FBCC 2457 PDA 28◦C
Candida krusei FBCC 2464 PDA 28◦C
Candida parapsilosis FBCC 2465 PDA 28◦C
Filobasidiella neoformans FBCC 2466 PDA 28◦C
Aspergillus niger FBCC 2467 PDA 28◦C
Aspergillus parasiticus FBCC 2500 PDA 28◦C
Aspergillus flavus FBCC 2467 PDA 28◦C
Bacteria
Staphylococcus aureus HAMBI 66 BHI 37◦C
Enterococcus faecium HAMBI 1821 BHI 37◦C
Bacillus cereus HAMBI 1881 BHI 37◦C
Micrococcus luteus HAMBI 2688 BHI 37◦C
Pseudomonas aeruginosa HAMBI 25 BHI 37◦C
Escherichia coli HAMBI 1723 BHI 37◦C
Acinetobacter baumannii HAMBI 1760 BHI 37◦C
Enterobacter aerogenes HAMBI 1898 BHI 37◦C
Salmonella enterica HAMBI 2331 BHI 37◦C
positive control (nystatin) (Nystatin, Streptomyces noursei, EMD
Millipore Corp, Germany) solution 5 mg/ml in methanol for
fungi and 10 µl ampicillin (Ampicillin sodium salt, Sigma,
Israel) 50 mg/ml in 70% ethanol for bacteria. Solvents were
allowed to evaporate, leaving the extracts diffused in the agar.
Inocula were prepared by growing the fungi for 2–14 days
on PDA (Potato Dextrose Agar) media at 28◦C and bacteria
for two days on BHI (Brain Heart Infusion) agar at 37◦C.
Cell mass was transferred with a cotton swab from the agar
to 3 ml of sterile 5 M NaCl solution or sterile water in
the case of A. flavus. The inocula were spread on the agar
with cotton swabs. Fungal plates were incubated at 28◦C
and bacterial plates at 37◦C for 2 days and analyzed for
inhibition zones.
The antifungal activity of purified scytocyclamide fractions
dissolved in methanol were tested with A. flavus performed as
with the cellular extract. Disk diffusion assays were performed
with purified scytocyclamides as follows. Paper disks (Blank
monodiscs, Abtek biologicals Ltd., United Kingdom) were
prepared with methanol solutions of the peptides, methanol as
a negative control, and nystatin as a positive control. A. flavus
inoculum was prepared as previously and spread on the plate.
Disks were placed on agar and the plates were incubated at 28◦C
for 2 days and analyzed.
Biosynthetic Gene Cluster Analysis
The S. hofmannii PCC 7110 draft genome sequence (ANNX02)
was analyzed with AntiSMASH 4.1 (Blin et al., 2017) to identify
the scytocyclamide biosynthetic gene clusters. AntiSMASH
recognized 9 NRPS/PKS coding regions in the draft genome.
The NRPS gene domain organization was compared to the
scytocyclamide structure and neighboring candidate pathways
for scytocyclamide biosynthesis were identified. Flanking genes
with the same orientation to the NRPSs were included in
the candidate biosynthetic gene cluster between 3,716,086-
3,812,822 bp. The biosynthetic gene cluster is limited from
both sides by genes with opposite orientation. Adenylation
domain substrate specificity prediction was performed by
combining differring AntiSMASH 4.1 and AntiSMASH 5.1.2
(Blin et al., 2019) results. The scytocyclamide biosynthetic gene
cluster was visualized using Artemis (Rutherford et al., 2000)
and functional annotations (Supplementary Table S2) were
manually refined using a combination of BLASTp and CDD
database searches.
The condensation domain of NRPS module LxaC3 was
analyzed with Natural Product Domain Seeker NaPDos (Ziemert
et al., 2012) to study the role of the condensation domain
in the biosynthesis of Dhb. The phylogenetic comparison was
made with condensation domains with a similar position to Dhb
in hassallidin biosynthesis (Vestola et al., 2014) and nodularin
biosynthesis (Jokela et al., 2017) with the condensation domains
of HasO2 and NdaA1, respectively.
RESULTS
Structure of Scytocyclamides
UPLC-QTOF analysis of S. hofmannii PCC 7110 methanol
extract yielded six peaks corresponding to six scytocyclamide
variants (Supplementary Figures S1, S2). Three of these
(scytocyclamides A-C) have been previously characterized
with spectrometric methods, including NMR. Three new less
abundant variants, scytocyclamides A2, B2, and B3 appeared to
be less hydroxylated (Figure 1, Table 3). The protonated masses
and relative intensities for each compound are shown in Table 4.
Product ion spectra (MSE) of protonated scytocyclamides A-C
showed that the amino acid sequence could be generated from
high-intensity ions in which Pro is N-terminal (Supplementary
Figures S3, S4). Application of this fragmentation behavior to
product ion spectra (MSE) of the new scytocyclamides A2, B2,
and B3 clearly showed the amino acids lacking a hydroxyl group
(Supplementary Figures S3, S4). Scytocyclamides A and A2
fall in 11-residue laxaphycins and scytocyclamides B-C fall in
12-residue laxaphycins. The yields for each compound were
1 mg (A), 1 mg (A2), 3 mg (B), 0.8 mg (C), 0.4 mg (B2),
and 0.4 mg (B3).
Scytocyclamide Biosynthetic Gene
Cluster
Analysis of the public 12.3-Mb draft genome of S. hofmannii
PCC 7110 identified 15 putative NRPS/PKS pathways in 9 regions
recognized by AntiSMASH (Table or figure reference). Two
sets of NRPSs with domain architecture matching the amino
acid sequences of the two scytocyclamide types were found,
separated from each other by a 9-kb region encoding 5 ORFs
(Figure 2). Surprisingly, just a single candidate enzyme for
the initiation of the biosynthetic pathways was found encoded
with the NRPS biosynthetic genes (Figure 2). Both types of
scytocyclamides contain β-aminooctanoic acid (Aoa) in their
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FIGURE 1 | Structures of 11- and 12-residue laxaphycin variants scytocyclamides.
TABLE 3 | Structures of scytocyclamides from S. hofmannii PCC 7110, with new variants A2, B2, and B3.
11-residue Laxaphycins 1 2 3 4 5 6 7 8 9 10 11
Scytocyclamide A Aoa L-Gln E-Dhb L-OHPro L-HSe D-Phe D-Leu L-Ile D-allo-Ile L-Leu Gly
Scytocyclamide A2 Aoa L-Gln E-Dhb L-Pro L-HSe D-Phe D-Leu L-Ile D-allo-Ile L-Leu Gly
12-residue Laxaphycins 1 2 3 4 5 6 7 8 9 10 11 12
Scytocyclamide B Aoa L-Val D-OHLeu L-Ala D-OHLeu L-Gln NMe-L-Ile D-OHAsn L-Thr L-Pro D-Leu L-Thr
Scytocyclamide B2 Aoa L-Val D-OHLeu L-Ala D-OHLeu L-Gln NMe-L-Ile D-Asn L-Thr L-Pro D-Leu L-Thr
Scytocyclamide B3 Aoa L-Val D-OHLeu L-Ala D-Leu L-Gln NMe-L-Ile D-Asn L-Thr L-Pro D-Leu L-Thr
Scytocyclamide C Aoa L-Val D-OHLeu L-Ala D-Leu L-Gln NMe-L-Ile D-OHAsn L-Thr L-Pro D-Leu L-Thr
Stereochemistry according to epimerase location in the biosynthetic gene cluster modules and Grewe (2005).
structures, and we predict that the two compounds share
the initiating biosynthetic enzymes for the production of Aoa
(Figure 2). The 96-kb biosynthetic gene cluster encodes 13
reading frames that were annotated lxaA-L, and ORF1 (Figure 2,
Supplementary Table S2).
The predicted biosynthesis of both scytocyclamide types
is initiated by the LxaA enzyme containing FAAL and ACP
domains and is predicted to activate and load a hexanoic
acid (Figure 2). The hexyl group is passed to the PKS
enzymes LxaB and LxaE (Figure 2). LxaB contains a single
ketosynthase (KS) domain and LxaE is composed of acyl
transferase (AT), ACP, and aminotransferase (AMT) domains
(Figure 2). These PKS domains elongate the hexyl chain with an
acyl group to octyl chain and the aminotransferase acts on the
carbonyl in the β position adding the amino group (Figure 2).
We predict that β-aminooctanoic acid has two alternative
branched pathways, the 11- or 12-residue scytocyclamide NRPSs
(Figure 2). In 11-residue scytocyclamide synthesis the LxaC-
D NRPSs and in 12-residue scytocyclamides the LxaA-D NRPS
enzymes incorporate the amino acids (Figure 2). Both pathways
have a terminal thioesterase (TE) that head-to-tail cyclize
and release the scytocyclamides. Each module of LxaC-D and
LxaI-L enzymes bears a condensation (C), adenylation (A),
and thiolation (T) domain (Figure 2). In addition, LxaC5,
LxaC6, LxaD2 and LxaI2, LxaJ1, LxaJ3, and LxaK4 modules
contain epimerase domains and LxaJ3 contains an N-methylation
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TABLE 4 | Scytocyclamides A–C from S. hofmannii PCC 7110.
tR [M + H]+
11-residue
laxaphycins
(min) Exp (m/z) 1 (ppm) Formula RI (%)
Scytocyclamide A 3.46 1223.7399 0,0 C61H99N12O14 98
Scytocyclamide A2 3.56 1207.7422 −2.3 C61H99N12O13 2
12-residue
laxaphycins
Scytocyclamide B 3.10 1367.8173 2.1 C63H111N14O19 50
Scytocyclamide B2 3.14 1351.8169 −2.0 C63H111N14O18 18
Scytocyclamide B3 3.27 1335.8228 −1.4 C63H111N14O17 10
Scytocyclamide C 3.23 1351.8190 −0.4 C63H111N14O18 22
Retention times (tR), experimental (Exp) mass of protonated scytocyclamides,
difference (1) to calculated mass, chemical formula, and relative intensity (RI) of
pronated scytocyclamides.
domain (Figure 2). The biosynthetic gene cluster encodes just
a single LxaH ABC-transporter, which is characteristic of NRPS
biosynthetic gene clusters.
The predicted adenylation domain substrate specificities of
LxaC-D and LxaI-L match with the amino acids incorporated
to scytocyclamides with some modifications (Supplementary
Table S3). The scytocyclamide chemical structures contain 3-
OHLeu, 3-OHAsn, 4-OHPro, and Dhb (Table 3). Scytocyclamide
chemical variants with hydroxylations are the most abundant
products produced by S. hofmannii PCC 7110 (Table 4). The
Leu-binding pockets are identical (DAWFLGNVVK) for each of
the four predicted Leu-activating adenylation domains (position
10 in 11-residue scytocyclamides and positions 3, 5, and 11
in 12-residue scytocyclamides) with the possible exception of a
gap in the adenylation domain amino aci sequence of position
3 (—FLGNVVK) (Supplementary Table S3). Cultivation of
S. hofmannii PCC 7110 in modified growth medium containing
racemic 3-OHLeu did not result in an increase of the relative
amounts of hydroxylated Leu-containing laxaphycin variants
(Supplementary Figure S5). This could indicate that LxaI2
and LxaJ1 adenylation domains incorporate Leu and not 3-
OHLeu, assuming that 3-OHLeu is transported into the cell.
S. hofmannii PCC 7110 incorporated the non-proteinogenic
amino acids (2S,4R)-4-MePro, (2R,4R)-4-MePro, (2S,4S)-4-
MePro, (2S,4S)-4-OHPro, and (2S,4R)-4-OHPro in parallel
cultivation experiments (data not shown). We predict that the
cupin 8 family proteins LxaF-G hydroxylates Leu and the Asn
after incorporation of the proteinogenic amino acids into the
peptide intermediate by the corresponding adenylation domain
(Figure 2). We did not find suitable candidate enzymes for
synthesis of 4-OHPro encoded in the biosynthetic gene cluster.
The modified AA clade of condensation domains is proposed
to play an active role in Thr dehydration during biosynthesis of
non-ribosomal peptides (Tillett et al., 2000; Moffitt and Neilan,
2004). The Dhb-tailoring condensation domains LxaC3, HasO2,
and NdaA1 were most similar to the modified AA clade of
condensation domains in phylogenetic analysis performed using
NaPDoS (Supplementary Figure S6).
Antimicrobial Activity
Antimicrobial activity of S. hofmannii PCC 7110 methanol
extracts was studied with several fungal and bacterial
strains (Table 2). The extracts inhibited only the growth of
A. flavus FBCC 2467. Disk diffusion assays were performed
after purification of the scytocyclamides from the extract.
Inhibition of fungal growth was observed with individual
scytocyclamides as a hazy inhibition zone and synergy was
observed between 11-residue and 12-residue compounds
as a noticeably increased clear inhibition zone (Figure 3).
Scytocyclamide amounts and inhibition zone diameters are
shown in Supplementary Table S4. Cross-contamination
between purified scytocyclamides A-D was from <1% to 5% and
15% for E (Supplementary Figure S7).
DISCUSSION
We described an unusual natural product biosynthetic gene
cluster for producing structurally distinct scytocyclamides.
Our analysis suggests that scytocyclamides have branched
biosynthesis and share loading modules LxaA-B and LxaE
(Figure 2 and Supplementary Table S2). These shared loading
modules initiate biosynthesis to produce the β-amino acid Aoa,
which is the only common amino acid in the peptide sequence
of the two structural distinct types of scytocyclamides. The
biosynthesis then branches to two NRPS pathways (Figure 2).
The organization of the catalytic domains in the NRPS enzymes
LxaC-D matches the structure of 11-residue scytocyclamides A
and A2 and NRPSs LxaI-L match the structure of 12-residue
scytocyclamides B, B2, B3, and C (Figure 2), as analyzed in
this study and reported earlier (Grewe, 2005). Such branching
is exceptional because natural product biosynthetic gene clusters
are typically self-contained and act independently following the
colinearity rule of PKS/NRPS biosynthesis (Guenzi et al., 1998;
Callahan et al., 2009; Baral et al., 2018). However, there are other
known exceptions to this rule. Modules can be skipped, as in
the case of anabaenopeptin and namalide synthesis in Nostoc sp.
CENA543, where the two compounds are produced by the same
gene cluster, but a shorter product namalide is produced when
three modules are skipped (Shishido et al., 2017). For example,
PKS domain skipping occurs in the synthesis of leinamycin (Tang
et al., 2006). Alternative starter modules have been found in
the synthesis of anabaenopeptins (Rouhiainen et al., 2010) and
puwainaphycins and minutissamides (Mareš et al., 2019). Gene
clusters have also been shown to share enzymes in producing
non-proteinogenic amino acids as in the case of anabaenopeptin
and spumigin (Lima et al., 2017) and aeruginosin and spumigin,
which results in the side product pseudoaeruginosin (Liu et al.,
2015). Crosstalk between NRPS clusters has also been found
in erythrochelin biosynthesis with two separate clusters sharing
essential biosynthetic enzymes (Lazos et al., 2010). Some NRPSs
incorporate multiple residues of the same amino acid iteratively,
as in enterobactin synthesis (Shaw-Reid et al., 1999). Shared
loading modules in laxaphycin biosynthesis are now presented as
a new exception to the colinearity rule of NRPS/PKS synthesis.
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FIGURE 2 | The scytocyclamide (lxa) biosynthetic gene cluster and putative biosynthetic scheme. (A) Organization of predicted scytocyclamide biosynthetic genes.
(B) Proposed biosynthetic pathway of scytocyclamides. NRPS, Non-ribosomal peptide synthetase, PKS, Polyketide synthase, FAAL, Fatty acyl AMP Ligase, ACP,
acyl carrier protein, KS, ketosynthase, AT, acyltransferase, AMT, aminotransferase, C, condensation domain, A, adenylation domain, T, thiolation domain, M,
methylation domain, TE, thioesterase domain.
FIGURE 3 | Inhibition of growth of Aspergillus flavus by scytocyclamides.
Scytocyclamide A2 (200 µg), scytocyclamide B2 (85 µg), and
scytocyclamides A2 + B2 (100 µg + 43 µg). Disk diameter is 5 mm.
Twelve-residue scytocyclamides have 3-OHLeu in positions
3 and 5 and 3-OHAsn in position 8. However, the adenylation
domain substrate specificity predictions are for proteinogenic
Leu and Asn with a 100% match (Supplementary Table S3). We
propose that the proteinogenic amino acids act as substrates for
the NRPS enzymes and the hydroxylation occurs after peptide-
bond formation. We propose that hydroxylation of Leu and
Asn residues in all scytocyclamides is performed by cupin 8-
like proteins encoded in the biosynthetic gene cluster. The
JmjC-like cupin 8 family (pfam13621) of proteins are Fe(II) or
Zn(II) and α-ketoglutarate (α-KG) dependent oxygenases and
act as hydroxylases and demethylases (Hewitson et al., 2002;
Markolovic et al., 2016). There are examples of hydroxylation of
Asn, Asp, His, Lys, Arg, and RNA in human and animal proteins
(Wilkins et al., 2018). The activity of cupin 8 is specific to the
amino acid position in the peptide. Their location within the
biosynthetic gene cluster suggests a role in the biosynthesis of
scytocyclamides. To our knowledge, this activity has not been
previously reported cupin 8 proteins. The hydroxylated amino
acids occur in modules with epimerase domains Figure 2. This
suggests that the enzymes hydroxylating the residues are specific
to D-amino acids or that the epimerase domains play a role in
the hydroxylation Figure 2. Other mechanisms have previously
been found to introduce 3-hydroxylated amino acids to NRPS
products (Hou et al., 2011). α-KG-dependent oxygenases
hydroxylate L-Arg in viomycin (Yin and Zabriskie, 2004), L-Asn
in daptomycin-like peptide (Strieker et al., 2007), and D-Glu in
kutzneride (Strieker et al., 2009) biosyntheses. No homologs to
these enzymes were found near the scytocyclamide cluster.
Dhb is enzymatically produced from Thr recognized by
the adenylation domain (Challis et al., 2000). In the case of
microcystin and nodularin synthesis, the dehydration has been
proposed to occur due to the active role of the following
condensation domain in the process (Tillett et al., 2000; Moffitt
and Neilan, 2004) and bleomycin synthesis (Du et al., 2000).
These microcystin and bleomycin condensation domains have
been assigned to their own clade of condensation domains
as “modified AA” C-domains (Ziemert et al., 2012; Bloudoff
and Schmeing, 2017). When the LxaC3 condensation domain
was analyzed by NaPDoS, it grouped with these modified
AA condensation domains (Supplementary Figure S6). The
similarity of these domains with direct contact to the modified
amino acid suggests that the Dhb and Dha dehydration could
be indeed catalyzed by the condensation domains in these
cases. For the Hse residues, no prediction was given by
AntiSMASH 5.1. However, a previous version, antiSMASH
4.1.0, did recognize the corresponding binding pocket sequence
for DLKNFGSDVK as Hse based on the Stachelhaus code.
Hse as an amino acid in NRPS products is less common
and in cyanobacteria has been previously seen in laxaphycin
family peptides and nostocyclopeptide M1 (Jokela et al., 2010).
However, the biosynthesis and adenylation domains for this
product have not been published. OHPro has been found in
other cyanobacterial natural products, such as nostoweipeptins
W1-W7 and nostopeptolides L1-L4 (Liu et al., 2014). The
process of incorporating the OHPro or hydroxylating the prolyl
residue remain unclear.
The catalytic domain organization of the scytocyclamide gene
cluster matches the laxaphycin family compound structures
reported earlier. The epimerizations are conserved in 11-
residue laxaphycins in positions 6, 7, and 9 and in 12-residue
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laxaphycins in positions 3, 5, 8, and 11. The N-methylation
of the amino acid in position 7 of the 12-residue laxaphycins
is also conserved. Dhb3 is conserved in the structures of
11-residue laxaphycins. The 3-OHLeu3 is conserved in 12-
residue laxaphycins and 3-OHLeu5 and 3-OHAsn8 are common
in 12-residue laxaphycins (Table 1). Bornancin et al. (2019)
predicted that laxaphycin gene clusters should have FAAL
and PKS modules to initiate biosynthesis, because the 11-
residue acyclic acyclolaxaphycins have a break just before
the Aoc and cyclization would be the last step of synthesis.
Bornancin et al. (2015) found acyclic 11-residue laxaphycin
variants with a gap between the second and third amino acid
in sequence starting with the Adc. They proposed that this gap
could be where the synthesis is finished and the cyclization
occurs, or that the compounds they found were cleaved
by environmental agents. Our results confirm the discovered
acyclic 11-residue variants could be immature products of
the pathway, as the linear peptide follows the biosynthetic
organization we have described. With the acyclic 12-residue
variants, the gap in the sequence occurs within a predicted
NRPS gene and the proposed mechanism of other agents or
enzymes in the environment cleaving the products would seem
more reasonable.
Cyanobacteria are abundant primary producers in aquatic
environments and are targeted to grazing by higher organisms,
such as sea hares (Cruz-Rivera and Paul, 2007). Cyanobacteria
produce a wide range of bioactive natural products (Dittmann
et al., 2015; Demay et al., 2019) that seem to be produced to
deter the grazing fauna in the environment (Leão et al., 2012;
Mazard et al., 2016). Potential competitors to cyanobacteria are
also other microbes such as chytrids, which are fungi parasitic
to cyanobacteria (Agha et al., 2018). Some cyanobacterial natural
products have reached clinical trials and are approved as cancer
drugs (Luesch et al., 2001; Deng et al., 2013). Cyclic lipopeptides
are common among the cyanobacterial natural products and
typically contain a single fatty acid as in laxaphycins (Galica et al.,
2017) that confers membrane-disruptive properties (Humisto
et al., 2019). Laxaphycin family peptides have been shown to
be toxic to or inhibit the growth of multiple organisms and cell
lines (Gerwick et al., 1989; Frankmölle et al., 1992b; Bonnard
et al., 1997, 2007; MacMillan et al., 2002; Maru et al., 2010;
Luo et al., 2014, 2015; Dussault et al., 2016; Cai et al., 2018;
Bornancin et al., 2019). We observed antifungal activity of
scytocyclamides toward A. flavus (Figure 3 and Supplementary
Table S4). In an earlier report by Grewe (2005), no activity against
C. albicans was detected for scytocyclamides A, B, and C, which
was also observed in this study. Synergistic antifungal activity
between 11- and 12-residue laxaphycins has been previously
reported (Frankmölle et al., 1992b; MacMillan et al., 2002). The
same synergistic activity was observed between 11- and 12-
residue scytocyclamides (Figure 3 and Supplementary Table S4).
According to previous studies and our results, the 12-residue
laxaphycins are typically more potent on their own than 11-
residue laxaphycins. Our previous study on S. hofmannii PCC
7110 failed to identify the antifungal agent in the extract, when
purified fractions lacked activity. We now conclude that the
antifungal activity was most probably caused by scytocyclamides,
but the purified fractions had insufficient amounts of material
to produce the inhibitory effect without a synergistic partner
(Shishido et al., 2015).
It is probable that the other type of laxaphycins originally
existed without a synergistic partner peptide in the cells, as
many laxaphycins have antimicrobial activity by themselves.
Through recombination events, a synergistically acting peptide
has emerged to enhance the activity of the original peptide. One
possibility is that the two peptides had individual gene clusters,
but the initiating enzymes have been subject to an elimination
event when two distinct starter enzymes were no longer
necessary. It is clear that the synergistic bioactivity and shared
biosynthesis of laxaphycins go together. Similar colocalization
with co-regulation of distinct synergistic biosynthetic gene
clusters has been previously observed in the streptomycetal
antibiotics griseoviridin and viridogrisein (Xie et al., 2012). The
mechanism behind the synergistic action is usually two different
compounds acting on two different targets, thus combining
their activity (Caesar and Cech, 2019). It is possible that one
compound makes the target cell vulnerable to the other, such as
via damage to the cell wall. The colocalization of genes and shared
biosynthesis suggest simultaneous regulation and expression of
the synergistic products to act on a single cellular target through
different mechanisms.
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